Correlation Between Oncorus and Landos Biopharma
Can any of the company-specific risk be diversified away by investing in both Oncorus and Landos Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncorus and Landos Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncorus and Landos Biopharma, you can compare the effects of market volatilities on Oncorus and Landos Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncorus with a short position of Landos Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncorus and Landos Biopharma.
Diversification Opportunities for Oncorus and Landos Biopharma
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Oncorus and Landos is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Oncorus and Landos Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Landos Biopharma and Oncorus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncorus are associated (or correlated) with Landos Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Landos Biopharma has no effect on the direction of Oncorus i.e., Oncorus and Landos Biopharma go up and down completely randomly.
Pair Corralation between Oncorus and Landos Biopharma
If you would invest 402.00 in Landos Biopharma on August 24, 2024 and sell it today you would earn a total of 0.00 from holding Landos Biopharma or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oncorus vs. Landos Biopharma
Performance |
| Timeline |
| Oncorus |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Landos Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Oncorus and Landos Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oncorus and Landos Biopharma
The main advantage of trading using opposite Oncorus and Landos Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncorus position performs unexpectedly, Landos Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Landos Biopharma will offset losses from the drop in Landos Biopharma's long position.| Oncorus vs. Apollomics Class A | Oncorus vs. Pyxis Oncology | Oncorus vs. Zura Bio Limited | Oncorus vs. Altamira Therapeutics |
| Landos Biopharma vs. Apollomics Class A | Landos Biopharma vs. Cardio Diagnostics Holdings | Landos Biopharma vs. Transcode Therapeutics | Landos Biopharma vs. Xenetic Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |